Cytoki Pharma
Værløse, DK · 5 known investors
Find your way into Cytoki Pharma
Cytoki is a biotech company developing IL-22-based therapeutics using lipidation technology to treat metabolic diseases such as obesity and type 2 diabetes, as well as conditions involving epithelial injury like inflammatory bowel disease. It focuses on drug discovery and clinical development for these indications.
Founders & leadership
RJ
Rasmus JorgensenCEO & Founder
Investors · 5
+ND CapitalWoodside · $540K – $5.4M
Ysios CapitalBarcelona · $5.4M – $21.6M
Seventure Partnersreported · 2 sourcesParis
Also in the syndicate · 2
Lundbeckfonden EmergeleadYsios
Funding
SEC filings, press & company announcements$45M disclosed across 1 round · 2021
- $45MSeries AMay 2021 · 2 sources
Lundbeckfonden Emerge (lead), +ND Capital, Seventure Partners, Ysios
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Cytoki Pharma do?
- Cytoki is a biotech company developing IL-22-based therapeutics using lipidation technology to treat metabolic diseases such as obesity and type 2 diabetes, as well as conditions involving epithelial injury like inflammatory bowel disease. It focuses on drug discovery and clinical development for these indications.
- Who founded Cytoki Pharma?
- Cytoki Pharma was founded by Rasmus Jorgensen.
- Who are Cytoki Pharma's investors?
- Cytoki Pharma's investors include +ND Capital, Ysios Capital, Seventure Partners.
- How much funding has Cytoki Pharma raised?
- Cytoki Pharma has disclosed $45M raised across 1 round.
- Where is Cytoki Pharma headquartered?
- Cytoki Pharma is headquartered in Værløse, DK.